Abstract
Medical industry, including pharmaceutical industry is cntered on growing expectations of a knowledge-intensive industry to lead the Japanese economy. However, Japanese pharmaceutical companies are subordinated to the global pharmaceutical companies. They seek to improve their status by innovative medical technologies. The innovators are being diversified to academia and start-up companies ; accompanying with progress of medical, engineering, and pharmaceutical research. In the medical industry, platform to lead open-innovation is required to improve in globalization.
